Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Cancer02:18

Cancer

54.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026
Same author

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Oncology·2026
Same author

Glue it together: self-assembly of the antibacterial GTPase GBP1.

Biological chemistry·2026
Same author

Could we reduce renal toxicity of [<sup>177</sup>Lu]Lu-PSMA radioligand therapy with furosemide?

European journal of nuclear medicine and molecular imaging·2026
Same author

The interplay of actual and perceived motor competencies, physical activity and well-being: a child-centered approach.

BMC public health·2026

Related Experiment Video

Updated: Feb 25, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K

Multiple primary tumours: challenges and approaches, a review.

Alexia Vogt1,2, Sabine Schmid1, Karl Heinimann3,4

  • 1Department of Oncology and Haematology, Kantonsspital St. Gallen, St.Gallen, Switzerland.

ESMO Open
|August 2, 2017
PubMed
Summary

Multiple primary tumors occur in 2-17% of cancer patients. Understanding varying definitions and risk factors is crucial for accurate analysis and clinical management of these complex cases.

Keywords:
Multiple primary cancerepidemiologygenetic predispositionmultiple primariessecond cancersecondary primary

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.3K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Related Experiment Videos

Last Updated: Feb 25, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

17.1K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.3K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Area of Science:

  • Oncology
  • Epidemiology
  • Genetics

Background:

  • Multiple primary tumors present diagnostic and epidemiological challenges.
  • Varied definitions exist, notably from Surveillance Epidemiology and End Results (SEER) and the International Association of Cancer Registries (IACR).
  • Analyzing reports on multiple primaries requires careful consideration of these definitional differences.

Purpose of the Study:

  • To review and summarize existing literature on multiple primary tumors.
  • To highlight epidemiological definitions, etiological factors, and clinical management strategies.
  • To provide guidance on suspecting and ruling out multiple primaries in clinical practice.

Main Methods:

  • Literature review and synthesis of published data on multiple primary tumors.
  • Discussion of epidemiological definitions and their implications.
  • Characterization of etiological factors, including host-related, lifestyle, and environmental influences.

Main Results:

  • The frequency of multiple primary tumors ranges from 2% to 17%.
  • Identified predisposing factors include host-related, lifestyle, and environmental influences.
  • Common cancer predisposition syndromes, genetic evaluations, and clinical suspicion criteria are discussed.

Conclusions:

  • Accurate analysis of multiple primary tumors necessitates understanding differing epidemiological definitions.
  • A comprehensive approach considering genetic predisposition, lifestyle, and environmental factors is essential.
  • Clinical vigilance and appropriate diagnostic strategies are key for managing synchronous and metachronous multiple primary tumors.